StockMacro
Company, fund or insider

Help

Menu

Joel Ackerman

Insider (Form 4 reporting owner): CFO and Treasurer CIK 1220630Name as filed: ACKERMAN JOELIts filings on EDGARAll insiders

Measures activity, not value. Not investment advice.

Since 20 Sep 2016, sold $25.9M in 4 sales and bought $37K in 5 open-market purchases across 2 companies.

Companies

Role on the latest Form 4 for each; open-market trades counted
CompanyRoleTrades fromtoPurchasesSales
DaVita DVACFO and Treasurer5 Aug 20217 May 2026–3$25.5M
Champions Oncology CSBRDirector20 Sep 20161 Oct 20185$37K1$384K

What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.

Median return minus the sector fund, in percentage points; "too few trades" under 5
Open-market tradesAfter 3 monthsAfter 6 monthsAfter 12 months
After purchasestoo few trades2 tradestoo few trades2 tradestoo few trades2 trades
After salestoo few trades4 tradestoo few trades4 tradestoo few trades3 trades

For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.

By year

Counted open-market trades, by trade date
YearPurchasesBoughtSalesSoldNet
2026––1$9.9M-$9.9M
2024––1$10.7M-$10.7M
2021––1$5.0M-$5.0M
2018––1$384K-$384K
20165$37K––$37K

Every trade

9, newest first; open-market purchases and sales only
Trade dateCompanySideSharesPriceValuePlanned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. Filing
7 May 2026DaVita DVASell51,471$192.10$9.9MNoForm 4filed 11 May 2026
27 Aug 2024DaVita DVASell68,769$155.06$10.7MNoForm 4filed 29 Aug 2024
5 Aug 2021DaVita DVASell37,760$131.36$5.0MNot statedForm 4filed 6 Aug 2021
1 Oct 2018Champions Oncology CSBRSell22,535$17.02$384KNot statedForm 4filed 3 Oct 2018
18 Oct 2016Champions Oncology CSBRBuy2,000$1.70$3KNot statedForm 4filed 20 Oct 2016
13 Oct 2016Champions Oncology CSBRBuy7,300$1.67$12KNot statedForm 4filed 14 Oct 2016
6 Oct 2016Champions Oncology CSBRBuy8,202$1.63$13KNot statedForm 4filed 7 Oct 2016
23 Sep 2016Champions Oncology CSBRBuy33$1.65$54.5Not statedForm 4filed 26 Sep 2016
20 Sep 2016Champions Oncology CSBRBuy5,000$1.67$8KNot statedForm 4filed 21 Sep 2016

From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.